|
1
|
Bartness TJ and Bamshad M: Innervation of
mammalian white adipose tissue: Implications for the regulation of
total body fat. Am J Physiol. 275:R1399–R1411. 1998.PubMed/NCBI
|
|
2
|
Bartness TJ and Song CK: Thematic review
series: Adipocyte biology. Sympathetic and sensory innervation of
white adipose tissue. J Lipid Res. 48:1655–1672. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fishman RB and Dark J: Sensory innervation
of white adipose tissue. Am J Physiol. 253:R942–R944.
1987.PubMed/NCBI
|
|
4
|
Giordano A, Morroni M, Santone G, Marchesi
GF and Cinti S: Tyrosine hydroxylase, neuropeptide Y, substance P,
calcitonin gene-related peptide and vasoactive intestinal peptide
in nerves of rat periovarian adipose tissue: An immunohistochemical
and ultrastructural investigation. J Neurocytol. 25:125–136. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shi H and Bartness TJ: White adipose
tissue sensory nerve denervation mimics lipectomy-induced
compensatory increases in adiposity. Am J Physiol Regul Integr Comp
Physiol. 289:R514–R520. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nicoll RA, Schenker C and Leeman SE:
Substance P as a transmitter candidate. Annu Rev Neurosci.
3:227–268. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maggi CA, Patacchini R, Rovero P and
Giachetti A: Tachykinin receptors and tachykinin receptor
antagonists. J Auton Pharmacol. 13:23–93. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mantyh PW: Neurobiology of substance P and
the NK1 receptor. J Clin Psychiatry. 63(Suppl 11): 6–10. 2002.
|
|
9
|
De Felipe C, Herrero JF, O'Brien JA,
Palmer JA, Doyle CA, Smith AJ, Laird JM, Belmonte C, Cervero F and
Hunt SP: Altered nociception, analgesia and aggression in mice
lacking the receptor for substance P. Nature. 392:394–397. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Quinlan KL, Song IS, Bunnett NW, Letran E,
Steinhoff M, Harten B, Olerud JE, Armstrong CA, Wright Caughman S
and Ansel JC: Neuropeptide regulation of human dermal microvascular
endothelial cell ICAM-1 expression and function. Am J Physiol.
275:C1580–C1590. 1998.PubMed/NCBI
|
|
11
|
Ho WZ, Lai JP, Zhu XH, Uvaydova M and
Douglas SD: Human monocytes and macrophages express substance P and
neurokinin-1 receptor. J Immunol. 159:5654–5660. 1997.
|
|
12
|
Miegueu P, St-Pierre DH, Lapointe M,
Poursharifi P, Lu H, Gupta A and Cianflone K: Substance P decreases
fat storage and increases adipocytokine production in 3T3-L1
adipocytes. Am J Physiol Gastrointest Liver Physiol. 304:G420–G427.
2013. View Article : Google Scholar
|
|
13
|
Jiang MH, Lim JE, Chi GF, Ahn W, Zhang M,
Chung E and Son Y: Substance P reduces apoptotic cell death
possibly by modulating the immune response at the early stage after
spinal cord injury. Neuroreport. 24:846–851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hong HS, Lee J, Lee E, Kwon YS, Lee E, Ahn
W, Jiang MH, Kim JC and Son Y: A new role of substance P as an
injury-inducible messenger for mobilization of CD29(+) stromal-like
cells. Nat Med. 15:425–435. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kant V, Gopal A and Kumar D, Bag S, Kurade
NP, Kumar A, Tandan SK and Kumar D: Topically applied substance P
enhanced healing of open excision wound in rats. Eur J Pharmacol.
715:345–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Delgado AV, McManus AT and Chambers JP:
Exogenous administration of Substance P enhances wound healing in a
novel skin-injury model. Exp Biol Med (Maywood). 230:271–280.
2005.
|
|
17
|
Karagiannides I, Stavrakis D, Bakirtzi K,
Kokkotou E, Pirtskhalava T, Nayeb-Hashemi H, Bowe C, Bugni JM, Nuño
M, Lu B, et al: Substance P (SP)-neurokinin-1 receptor (NK-1R)
alters adipose tissue responses to high-fat diet and insulin
action. Endocrinology. 152:2197–2205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guilherme A, Virbasius JV, Puri V and
Czech MP: Adipocyte dysfunctions linking obesity to insulin
resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 9:367–377.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kahn SE, Hull RL and Utzschneider KM:
Mechanisms linking obesity to insulin resistance and type 2
diabetes. Nature. 444:840–846. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wellen KE and Hotamisligil GS:
Inflammation, stress, and diabetes. J Clin Invest. 115:1111–1119.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Scherer PE: Adipose tissue: From lipid
storage compartment to endocrine organ. Diabetes. 55:1537–1545.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koranyi L, James D, Mueckler M and Permutt
MA: Glucose transporter levels in spontaneously obese (db/db)
insulin-resistant mice. J Clin Invest. 85:962–967. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garvey WT, Maianu L, Huecksteadt TP,
Birnbaum MJ, Molina JM and Ciaraldi TP: Pretranslational
suppression of a glucose transporter protein causes insulin
resistance in adipocytes from patients with non-insulin-dependent
diabetes mellitus and obesity. J Clin Invest. 87:1072–1081. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Coughlan KA, Valentine RJ, Ruderman NB and
Saha AK: AMPK activation: A therapeutic target for type 2 diabetes?
Diabetes Metab Syndr Obes. 7:241–253. 2014.PubMed/NCBI
|
|
25
|
Ruderman N and Prentki M: AMP kinase and
malonyl-CoA: Targets for therapy of the metabolic syndrome. Nat Rev
Drug Discov. 3:340–351. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hardie DG, Ross FA and Hawley SA: AMPK: A
nutrient and energy sensor that maintains energy homeostasis. Nat
Rev Mol Cell Biol. 13:251–262. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mihaylova MM and Shaw RJ: The AMPK
signalling pathway coordinates cell growth, autophagy and
metabolism. Nat Cell Biol. 13:1016–1023. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu X, Motoshima H, Mahadev K, Stalker TJ,
Scalia R and Goldstein BJ: Involvement of AMP-activated protein
kinase in glucose uptake stimulated by the globular domain of
adiponectin in primary rat adipocytes. Diabetes. 52:1355–1363.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bolsoni-Lopes A, Festuccia WT, Chimin P,
Farias TS, Torres-Leal FL, Cruz MM, Andrade PB, Hirabara SM, Lima
FB and Alonso-Vale MI: Palmitoleic acid (n-7) increases white
adipocytes GLUT4 content and glucose uptake in association with
AMPK activation. Lipids Health Dis. 13(199)2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Richter EA and Hargreaves M: Exercise,
GLUT4, and skeletal muscle glucose uptake. Physiol Rev.
93:993–1017. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang LH, Zhou SX, Li RC, Zheng LR, Zhu JH,
Hu SJ and Sun YL: Serum levels of calcitonin gene-related peptide
and substance P are decreased in patients with diabetes mellitus
and coronary artery disease. J Int Med Res. 40:134–140. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lindberger M, Schröder HD, Schultzberg M,
Kristensson K, Persson A, Ostman J and Link H: Nerve fibre studies
in skin biopsies in peripheral neuropathies. I. Immunohistochemical
analysis of neuropeptides in diabetes mellitus. J Neurol Sci.
93:289–296. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song JX, Wang LH, Yao L, Xu C, Wei ZH and
Zheng LR: Impaired transient receptor potential vanilloid 1 in
streptozotocin-induced diabetic hearts. Int J Cardiol. 134:290–292.
2009. View Article : Google Scholar
|
|
34
|
Fu J, Liu B, Liu P, Liu L, Li G, Wu B and
Liu X: Substance P is associated with the development of obesity,
chronic inflammation and type 2 diabetes mellitus. Exp Clin
Endocrinol Diabetes. 119:177–181. 2011. View Article : Google Scholar
|
|
35
|
Gross K, Karagiannides I, Thomou T, Koon
HW, Bowe C, Kim H, Giorgadze N, Tchkonia T, Pirtskhalava T,
Kirkland JL, et al: Substance P promotes expansion of human
mesenteric preadipocytes through proliferative and antiapoptotic
pathways. Am J Physiol Gastrointest Liver Physiol. 296:G1012–G1019.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Albrektsen T, Frederiksen KS, Holmes WE,
Boel E, Taylor K and Fleckner J: Novel genes regulated by the
insulin sensitizer rosiglitazone during adipocyte differentiation.
Diabetes. 51:1042–1051. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rosen ED, Walkey CJ, Puigserver P and
Spiegelman BM: Transcriptional regulation of adipogenesis. Genes
Dev. 14:1293–1307. 2000.PubMed/NCBI
|
|
38
|
Towler MC and Hardie DG: AMP-activated
protein kinase in metabolic control and insulin signaling. Circ
Res. 100:328–341. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hahn-Windgassen A, Nogueira V, Chen CC,
Skeen JE, Sonenberg N and Hay N: Akt activates the mammalian target
of rapamycin by regulating cellular ATP level and AMPK activity. J
Biol Chem. 280:32081–32089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee WH, Lin RJ, Lin SY, Chen YC, Lin HM
and Liang YC: Osthole enhances glucose uptake through activation of
AMP-activated protein kinase in skeletal muscle cells. J Agric Food
Chem. 59:12874–12881. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shen Y, Honma N, Kobayashi K, Jia LN,
Hosono T, Shindo K, Ariga T and Seki T: Cinnamon extract enhances
glucose uptake in 3T3-L1 adipocytes and C2C12 myocytes by inducing
LKB1-AMP-activated protein kinase signaling. PLoS One.
9:e878942014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xu J and Liao K: Protein kinase B/AKT 1
plays a pivotal role in insulin-like growth factor-1 receptor
signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem.
279:35914–35922. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Peng XD, Xu PZ, Chen ML, Hahn-Windgassen
A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman
KG, et al: Dwarfism, impaired skin development, skeletal muscle
atrophy, delayed bone development, and impeded adipogenesis in mice
lacking Akt1 and Akt2. Genes Dev. 17:1352–1365. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kohn AD, Summers SA, Birnbaum MJ and Roth
RA: Expression of a constitutively active Akt Ser/Thr kinase in
3T3-L1 adipocytes stimulates glucose uptake and glucose transporter
4 translocation. J Biol Chem. 271:31372–31378. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shepherd PR and Kahn BB: Glucose
transporters and insulin action - implications for insulin
resistance and diabetes mellitus. N Engl J Med. 341:248–257. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hayashi T, Hirshman MF, Kurth EJ, Winder
WW and Goodyear LJ: Evidence for 5′ AMP-activated protein kinase
mediation of the effect of muscle contraction on glucose transport.
Diabetes. 47:1369–1373. 1998.PubMed/NCBI
|
|
47
|
Ruschke K, Ebelt H, Klöting N, Boettger T,
Raum K, Blüher M and Braun T: Defective peripheral nerve
development is linked to abnormal architecture and metabolic
activity of adipose tissue in Nscl-2 mutant mice. PLoS One.
4:e55162009. View Article : Google Scholar : PubMed/NCBI
|
